Nihar R Desai1, Joseph S Ross2, Ji Young Kwon3, Jeph Herrin4, Kumar Dharmarajan1, Susannah M Bernheim3, Harlan M Krumholz5, Leora I Horwitz6. 1. Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, New Haven, Connecticut. 2. Center for Outcomes Research and Evaluation, New Haven, Connecticut3Section of General Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut4Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut5Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut. 3. Center for Outcomes Research and Evaluation, New Haven, Connecticut. 4. Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut6Health Research and Educational Trust, Chicago, Illinois. 5. Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, New Haven, Connecticut4Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut5Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut. 6. Division of Healthcare Delivery Science, Department of Population Health, NYU School of Medicine, New York, New York8Center for Healthcare Innovation and Delivery Science, NYU Langone Medical Center, New York, New York9Department of Medicine, NYU School of Medicine, New York, New York.
Abstract
Importance: Readmission rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which penalizes hospitals for excess readmissions for acute myocardial infarction (AMI), heart failure (HF), and pneumonia. Objective: To compare trends in readmission rates for target and nontarget conditions, stratified by hospital penalty status. Design, Setting, and Participants: Retrospective cohort study of Medicare fee-for-service beneficiaries older than 64 years discharged between January 1, 2008, and June 30, 2015, from 2214 penalty hospitals and 1283 nonpenalty hospitals. Difference-interrupted time-series models were used to compare trends in readmission rates by condition and penalty status. Exposure: Hospital penalty status or target condition under the HRRP. Main Outcomes and Measures: Thirty-day risk adjusted, all-cause unplanned readmission rates for target and nontarget conditions. Results: The study included 48 137 102 hospitalizations of 20 351 161 Medicare beneficiaries. In January 2008, the mean readmission rates for AMI, HF, pneumonia, and nontarget conditions were 21.9%, 27.5%, 20.1%, and 18.4%, respectively, at hospitals later subject to financial penalties and 18.7%, 24.2%, 17.4%, and 15.7% at hospitals not subject to penalties. Between January 2008 and March 2010, prior to HRRP announcement, readmission rates were stable across hospitals (except AMI at nonpenalty hospitals). Following announcement of HRRP (March 2010), readmission rates for both target and nontarget conditions declined significantly faster for patients at hospitals later subject to financial penalties compared with those at nonpenalized hospitals (for AMI, additional decrease of -1.24 [95% CI, -1.84 to -0.65] percentage points per year relative to nonpenalty discharges; for HF, -1.25 [95% CI, -1.64 to -0.86]; for pneumonia, -1.37 [95% CI, -1.80 to -0.95]; and for nontarget conditions, -0.27 [95% CI, -0.38 to -0.17]; P < .001 for all). For penalty hospitals, readmission rates for target conditions declined significantly faster compared with nontarget conditions (for AMI, additional decline of -0.49 [95% CI, -0.81 to -0.16] percentage points per year relative to nontarget conditions [P = .004]; for HF, -0.90 [95% CI, -1.18 to -0.62; P < .001]; and for pneumonia, -0.57 [95% CI, -0.92 to -0.23; P < .001]). In contrast, among nonpenalty hospitals, readmissions for target conditions declined similarly or more slowly compared with nontarget conditions (for AMI, additional increase of 0.48 [95% CI, 0.01-0.95] percentage points per year [P = .05]; for HF, 0.08 [95% CI, -0.30 to 0.46; P = .67]; for pneumonia, 0.53 [95% CI, 0.13-0.93; P = .01]). After HRRP implementation in October 2012, the rate of change for readmission rates plateaued (P < .05 for all except pneumonia at nonpenalty hospitals), with the greatest relative change observed among hospitals subject to financial penalty. Conclusions and Relevance: Medicare fee-for-service patients at hospitals subject to penalties under the HRRP had greater reductions in readmission rates compared with those at nonpenalized hospitals. Changes were greater for target vs nontarget conditions for patients at the penalized hospitals but not at the other hospitals.
Importance: Readmission rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which penalizes hospitals for excess readmissions for acute myocardial infarction (AMI), heart failure (HF), and pneumonia. Objective: To compare trends in readmission rates for target and nontarget conditions, stratified by hospital penalty status. Design, Setting, and Participants: Retrospective cohort study of Medicare fee-for-service beneficiaries older than 64 years discharged between January 1, 2008, and June 30, 2015, from 2214 penalty hospitals and 1283 nonpenalty hospitals. Difference-interrupted time-series models were used to compare trends in readmission rates by condition and penalty status. Exposure: Hospital penalty status or target condition under the HRRP. Main Outcomes and Measures: Thirty-day risk adjusted, all-cause unplanned readmission rates for target and nontarget conditions. Results: The study included 48 137 102 hospitalizations of 20 351 161 Medicare beneficiaries. In January 2008, the mean readmission rates for AMI, HF, pneumonia, and nontarget conditions were 21.9%, 27.5%, 20.1%, and 18.4%, respectively, at hospitals later subject to financial penalties and 18.7%, 24.2%, 17.4%, and 15.7% at hospitals not subject to penalties. Between January 2008 and March 2010, prior to HRRP announcement, readmission rates were stable across hospitals (except AMI at nonpenalty hospitals). Following announcement of HRRP (March 2010), readmission rates for both target and nontarget conditions declined significantly faster for patients at hospitals later subject to financial penalties compared with those at nonpenalized hospitals (for AMI, additional decrease of -1.24 [95% CI, -1.84 to -0.65] percentage points per year relative to nonpenalty discharges; for HF, -1.25 [95% CI, -1.64 to -0.86]; for pneumonia, -1.37 [95% CI, -1.80 to -0.95]; and for nontarget conditions, -0.27 [95% CI, -0.38 to -0.17]; P < .001 for all). For penalty hospitals, readmission rates for target conditions declined significantly faster compared with nontarget conditions (for AMI, additional decline of -0.49 [95% CI, -0.81 to -0.16] percentage points per year relative to nontarget conditions [P = .004]; for HF, -0.90 [95% CI, -1.18 to -0.62; P < .001]; and for pneumonia, -0.57 [95% CI, -0.92 to -0.23; P < .001]). In contrast, among nonpenalty hospitals, readmissions for target conditions declined similarly or more slowly compared with nontarget conditions (for AMI, additional increase of 0.48 [95% CI, 0.01-0.95] percentage points per year [P = .05]; for HF, 0.08 [95% CI, -0.30 to 0.46; P = .67]; for pneumonia, 0.53 [95% CI, 0.13-0.93; P = .01]). After HRRP implementation in October 2012, the rate of change for readmission rates plateaued (P < .05 for all except pneumonia at nonpenalty hospitals), with the greatest relative change observed among hospitals subject to financial penalty. Conclusions and Relevance: Medicare fee-for-service patients at hospitals subject to penalties under the HRRP had greater reductions in readmission rates compared with those at nonpenalized hospitals. Changes were greater for target vs nontarget conditions for patients at the penalized hospitals but not at the other hospitals.
Authors: Adam D DeVore; Bradley G Hammill; N Chantelle Hardy; Zubin J Eapen; Eric D Peterson; Adrian F Hernandez Journal: J Am Coll Cardiol Date: 2016-03-01 Impact factor: 24.094
Authors: Patricia S Keenan; Sharon-Lise T Normand; Zhenqiu Lin; Elizabeth E Drye; Kanchana R Bhat; Joseph S Ross; Jeremiah D Schuur; Brett D Stauffer; Susannah M Bernheim; Andrew J Epstein; Yongfei Wang; Jeph Herrin; Jersey Chen; Jessica J Federer; Jennifer A Mattera; Yun Wang; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2008-09
Authors: Rachael B Zuckerman; Steven H Sheingold; E John Orav; Joel Ruhter; Arnold M Epstein Journal: N Engl J Med Date: 2016-02-24 Impact factor: 91.245
Authors: Leora I Horwitz; Chohreh Partovian; Zhenqiu Lin; Jacqueline N Grady; Jeph Herrin; Mitchell Conover; Julia Montague; Chloe Dillaway; Kathleen Bartczak; Lisa G Suter; Joseph S Ross; Susannah M Bernheim; Harlan M Krumholz; Elizabeth E Drye Journal: Ann Intern Med Date: 2014-11-18 Impact factor: 25.391
Authors: Peter K Lindenauer; Sharon-Lise T Normand; Elizabeth E Drye; Zhenqiu Lin; Katherine Goodrich; Mayur M Desai; Dale W Bratzler; Walter J O'Donnell; Mark L Metersky; Harlan M Krumholz Journal: J Hosp Med Date: 2011-01-05 Impact factor: 2.960
Authors: Harlan M Krumholz; Zhenqiu Lin; Elizabeth E Drye; Mayur M Desai; Lein F Han; Michael T Rapp; Jennifer A Mattera; Sharon-Lise T Normand Journal: Circ Cardiovasc Qual Outcomes Date: 2011-03
Authors: Marc D Samsky; Andrew P Ambrosy; Erik Youngson; Li Liang; Padma Kaul; Adrian F Hernandez; Eric D Peterson; Finlay A McAlister Journal: JAMA Cardiol Date: 2019-05-01 Impact factor: 14.676
Authors: Sara C LaHue; Vanja C Douglas; Teresa Kuo; Carol A Conell; Vincent X Liu; S Andrew Josephson; Clay Angel; Kristen B Brooks Journal: J Hosp Med Date: 2019-04 Impact factor: 2.960
Authors: Enrico G Ferro; Eric A Secemsky; Rishi K Wadhera; Eunhee Choi; Jordan B Strom; Jason H Wasfy; Yun Wang; Changyu Shen; Robert W Yeh Journal: Health Aff (Millwood) Date: 2019-04 Impact factor: 6.301
Authors: Katherine A Auger; J Mitchell Harris; James C Gay; Ronald Teufel; Richard E McClead; Mark I Neuman; Rishi Agrawal; Harold K Simon; Alon Peltz; Javier Tejedor-Sojo; Rustin B Morse; Mark A Del Beccaro; Evan Fieldston; Samir S Shah Journal: J Hosp Med Date: 2019-06-19 Impact factor: 2.960
Authors: Muthiah Vaduganathan; Cian P McCarthy; Colby Ayers; Deepak L Bhatt; Dharam J Kumbhani; James A de Lemos; Gregg C Fonarow; Ambarish Pandey Journal: Eur Heart J Qual Care Clin Outcomes Date: 2020-01-01
Authors: Tudor Borza; Mary K Oerline; Ted A Skolarus; Edward C Norton; Justin B Dimick; Bruce L Jacobs; Lindsey A Herrel; Chad Ellimoottil; John M Hollingsworth; Andrew M Ryan; David C Miller; Vahakn B Shahinian; Brent K Hollenbeck Journal: Ann Surg Date: 2019-05 Impact factor: 12.969
Authors: Jason H Wasfy; Kevin F Kennedy; Frederick A Masoudi; Timothy G Ferris; Suzanne V Arnold; Vinay Kini; Pamela Peterson; Jeptha P Curtis; Amit P Amin; Steven M Bradley; William J French; John Messenger; P Michael Ho; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2018-09
Authors: Harlan M Krumholz; Kun Wang; Zhenqiu Lin; Kumar Dharmarajan; Leora I Horwitz; Joseph S Ross; Elizabeth E Drye; Susannah M Bernheim; Sharon-Lise T Normand Journal: N Engl J Med Date: 2017-09-14 Impact factor: 91.245